British American Tobacco

H1 2026 in line with expectations

30/07/26 -"The H1 2026 results were supported by strong momentum in New categories, led by Modern Oral and the successful roll-out of Velo Plus in the US, and a favourable price/mix in Combustibles despite ..."

PDF page sample
Pages
51
Language
English
Published on
30/07/26
Download
You may also be interested by these reports :
30/07/26
AB InBev delivered another solid quarter, combining positive beer volumes with strong revenue per hectolitre and double-digit underlying EPS growth. ...
30/07/26
The H1 2026 results were supported by strong momentum in New categories, led by Modern Oral and the successful roll-out of Velo Plus in the US, and a ...
29/07/26
Campari reported strong H1 results, demonstrating broad-based market share gains, an improved product mix, and disciplined SG&A management. This ...
29/07/26
Rémy Cointreau reported slightly above expectations for Q1, driven by Cognac and stronger sell-out compared to sell-in. However, the momentum remains ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO